Amedisys Acquires a Home Care and Hospice Business
03 March 2007 - 1:03AM
PR Newswire (US)
- Acquisition Furthers Amedisys' Presence in Texas - BATON ROUGE,
La., March 2 /PRNewswire-FirstCall/ -- Amedisys, Inc. (Nasdaq: AMED
or the "Company"), one of America's leading home health nursing
companies, today announced the acquisition of a home care and
hospice business providing services in the greater San Antonio,
Texas area. The transaction was effective as of March 1, 2007, and
is expected to contribute approximately $5.4 million in total
annualized revenues. "We are excited to further expand our home
care services in Texas with this acquisition," said William F.
Borne, Chief Executive Officer of Amedisys, Inc. "The acquisition
of OptimaCare Home Health, Inc. will be our sixteenth home health
location in Texas, and MissionPlus Healthcare LLC will mark our
first hospice location in the state." "This purchase is
representative of our disciplined acquisition strategy to increase
our geographic coverage," continued Mr. Borne. "We continuously
assess many similar opportunities in order to identify those that
most appropriately fit our profile and acquisition criteria." The
acquisition is not expected to add materially to Amedisys' earnings
in 2007. Terms of the acquisition purchase agreement were not
disclosed. Amedisys, Inc. is headquartered in Baton Rouge,
Louisiana. Its common stock trades on the Nasdaq Global Select
Market under the symbol "AMED". This press release includes
statements that may constitute "forward- looking" statements,
usually containing the words "believe", "estimate", "project",
"expect" or similar expressions. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
Factors that would cause or contribute to such differences include,
but are not limited to, continued acceptance of the Company's
services in the marketplace, competitive factors, changes in
government reimbursement procedures, dependence upon third-party
vendors, and other risks discussed in the Company's periodic
filings with the Securities and Exchange Commission. By making
these forward- looking statements, the Company undertakes no
obligation to update these statements for revisions or changes
after the date of this release. Additional information on the
Company can be found at: http://www.amedisys.com/ Contact:
Amedisys, Inc. President and Chief Operating Officer Larry R.
Graham 225.292.2031 DATASOURCE: Amedisys, Inc. CONTACT: Larry R.
Graham, President and Chief Operating Officer, Amedisys, Inc.,
+1-225-292-2031, Web site: http://www.amedisys.com/
Copyright